drug
TYENNE
Marketedupdated 3mo agoby Fresenius Kabi USA LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 5all catalysts(8)
approval · 8
Mar 5, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Sep 5, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Dec 3, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Dec 13, 2024
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Feb 28, 2025
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Mar 13, 2025
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
May 12, 2025
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Jan 21, 2026
approval
TYENNE (TOCILIZUMAB-AAZG) — FDA approval
TYENNE
→
Trials studying TYENNE
News(1)
- Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass ParticlesFOR IMMEDIATE RELEASE – August 10, 2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (…fda_recalls · 8d ago
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that